Norfolk Southern Corporation (LON:0K8M)

Theseus Pharmaceuticals Statistics

Total Valuation

LON:0K8M has a market cap or net worth of GBP 46.55 billion. The enterprise value is 59.08 billion.

Market Cap	46.55B
Enterprise Value	59.08B

Important Dates

The last earnings date was Friday, July 25, 2025.

Earnings Date	Jul 25, 2025
Ex-Dividend Date	Aug 1, 2025

Share Statistics

Current Share Class	224.35M
Shares Outstanding	n/a
Shares Change (YoY)	-0.16%
Shares Change (QoQ)	-0.57%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	223.95M

Valuation Ratios

The trailing PE ratio is 19.06 and the forward PE ratio is 20.90.

PE Ratio	19.06
Forward PE	20.90
PS Ratio	5.24
PB Ratio	4.31
P/TBV Ratio	4.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.14, with an EV/FCF ratio of 39.99.

EV / Earnings	24.18
EV / Sales	6.43
EV / EBITDA	12.14
EV / EBIT	16.71
EV / FCF	39.99

Financial Position

The company has a current ratio of 0.79, with a Debt / Equity ratio of 1.21.

Current Ratio	0.79
Quick Ratio	0.66
Debt / Equity	1.21
Debt / EBITDA	2.78
Debt / FCF	8.84
Interest Coverage	5.84

Financial Efficiency

Return on equity (ROE) is 24.13% and return on invested capital (ROIC) is 9.18%.

Return on Equity (ROE)	24.13%
Return on Assets (ROA)	6.75%
Return on Invested Capital (ROIC)	9.18%
Return on Capital Employed (ROCE)	11.57%
Revenue Per Employee	453,506
Profits Per Employee	124,642
Employee Count	19,600
Asset Turnover	0.28
Inventory Turnover	19.72

Taxes

In the past 12 months, LON:0K8M has paid 716.03 million in taxes.

Income Tax	716.03M
Effective Tax Rate	22.65%

Stock Price Statistics

The stock price has increased by +13.55% in the last 52 weeks. The beta is 1.30, so LON:0K8M's price volatility has been higher than the market average.

Beta (5Y)	1.30
52-Week Price Change	+13.55%
50-Day Moving Average	259.29
200-Day Moving Average	247.92
Relative Strength Index (RSI)	56.05
Average Volume (20 Days)	170

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.52

Income Statement

In the last 12 months, LON:0K8M had revenue of GBP 8.89 billion and earned 2.44 billion in profits. Earnings per share was 10.81.

Revenue	8.89B
Gross Profit	4.42B
Operating Income	3.42B
Pretax Income	3.16B
Net Income	2.44B
EBITDA	4.42B
EBIT	3.42B
Earnings Per Share (EPS)	10.81

Balance Sheet

The company has 951.06 million in cash and 13.07 billion in debt, giving a net cash position of -12.11 billion.

Cash & Cash Equivalents	951.06M
Total Debt	13.07B
Net Cash	-12.11B
Net Cash Per Share	n/a
Equity (Book Value)	10.79B
Book Value Per Share	48.05
Working Capital	-554.72M

Cash Flow

In the last 12 months, operating cash flow was 3.07 billion and capital expenditures -1.59 billion, giving a free cash flow of 1.48 billion.

Operating Cash Flow	3.07B
Capital Expenditures	-1.59B
Free Cash Flow	1.48B
FCF Per Share	n/a

Margins

Gross margin is 49.73%, with operating and profit margins of 38.45% and 27.51%.

Gross Margin	49.73%
Operating Margin	38.45%
Pretax Margin	35.56%
Profit Margin	27.51%
EBITDA Margin	49.73%
EBIT Margin	38.45%
FCF Margin	16.62%

Dividends & Yields

This stock pays an annual dividend of 4.17, which amounts to a dividend yield of 1.47%.

Dividend Per Share	4.17
Dividend Yield	1.47%
Dividend Growth (YoY)	-3.27%
Years of Dividend Growth	n/a
Payout Ratio	36.42%
Buyback Yield	0.16%
Shareholder Yield	1.63%
Earnings Yield	5.25%
FCF Yield	3.17%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0K8M has an Altman Z-Score of 2.13 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.13
Piotroski F-Score	7